News
$Syndax Pharmaceuticals (SNDX.US)$ Reuters· 2 mins ago
Syndax Pharmaceuticals Inc - Primary Endpoint Met With 23% Cr/CRH Rate in Phase 2 Trial
Syndax Pharmaceuticals Inc - Primary Endpoint Met With 23% Cr/CRH Rate in Phase 2 Trial
Disclaimer: Community is offered by Moomoo Technologies Inc. and is for educational purposes only.
Read more
Comment
Sign in to post a comment